Evidence map›Paper›PMID 40293623›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Emerging West Nile virus infections in Türkiye.

Özlem Alhan, Meliha Meriç Koç, Ayşe Batırel, Emel Yılmaz, Gülden Ersöz, Mehtap Aydın, Merve Üstüner Doğan, Hande Hazır Konya, Üner Kayabaş, Ferit Kuşçu and 7 more

Abstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Özlem AlhanInfectious Diseases and Clinical Microbiology, Koç University Hospital, İstanbul, Türkiye. oalhan@kuh.ku.edu.tr.ORCID http://orcid.org/0000-0002-2540-7945
Meliha Meriç KoçInfectious Diseases and Clinical Microbiology, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID http://orcid.org/0000-0002-0563-6900
Ayşe BatırelInfectious Diseases and Clinical Microbiology, University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Türkiye.ORCID http://orcid.org/0000-0002-6005-636X
Emel YılmazInfectious Diseases and Clinical Microbiology, Bursa Uludağ University Faculty of Medicine, Bursa, Türkiye.ORCID http://orcid.org/0000-0002-3894-1231
Gülden ErsözInfectious Diseases and Clinical Microbiology, Mersin University Faculty of Medicine, Mersin, Türkiye.ORCID http://orcid.org/0000-0003-2836-3586
Mehtap AydınInfectious Diseases and Clinical Microbiology, Ümraniye Training and Research Hospital, Istanbul, Türkiye.ORCID http://orcid.org/0000-0003-4044-9366
Merve Üstüner DoğanInfectious Diseases and Clinical Microbiology, Adana Training and Research Hospital, Adana, Türkiye.ORCID http://orcid.org/0009-0003-9791-5433
Hande Hazır KonyaInfectious Diseases and Clinical Microbiology, Adnan Menderes University Faculty of Medicine, Aydın, Türkiye.ORCID http://orcid.org/0000-0001-8389-9565
Üner KayabaşInfectious Diseases and Clinical Microbiology, University of Health Sciences, Kayseri City Hospital, Kayseri, Türkiye.ORCID http://orcid.org/0000-0002-5323-0796
Ferit KuşçuInfectious Diseases and Clinical Microbiology, Çukurova University Faculty of Medicine, Adana, Türkiye.ORCID http://orcid.org/0000-0001-5662-8305
Zehra Çağla KarakoçInfectious Diseases and Clinical Microbiology, İstinye University Faculty of Medicine, İstanbul, Türkiye.ORCID http://orcid.org/0000-0002-1618-740X
Meryem Şahin ÖzdemirInfectious Diseases and Clinical Microbiology, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.
Ali Okay ElibolInfectious Diseases and Clinical Microbiology, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.
Esra KazakInfectious Diseases and Clinical Microbiology, Bursa Uludağ University Faculty of Medicine, Bursa, Türkiye.ORCID http://orcid.org/0000-0002-7380-2501
İdil KaracaInfectious Diseases and Clinical Microbiology, Mersin University Faculty of Medicine, Mersin, Türkiye.
Mert Ahmet KuşkucuMedical Microbiology, Koç University Faculty of Medicine, İstanbul, Türkiye.ORCID http://orcid.org/0000-0001-8735-5725
Önder ErgönülInfectious Diseases and Clinical Microbiology, Koç University Faculty of Medicine, İstanbul, Türkiye.ORCID http://orcid.org/0000-0003-1935-9235

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTürkiye experienced its largest West Nile virus (WNV) infection outbreak in 2024. We described the clinical and laboratory features of human cases with WNV infection collected from eleven tertiary hospitals in Türkiye in 2024.

methodsThe clinical characteristics of the patients were gathered using a structured form in the retrospective study. According to the ECDC case definition of WNV infections, the patients were classified as 'confirmed' or 'probable' cases. The odds ratio (OR) and 95% confidence interval (CI) for possible mortality predictors in WNV infections were calculated using multivariate logistic regression analysis. p < 0.05 was considered statistically significant.

resultsThe mean age of the 51 patients was 63.3 ± 13.6 years, and 37 (72.5%) were male. Twenty-six cases (51%) were confirmed, and 49% were probable WNV infection. Forty-eight patients (94.1%) had WNV neuroinvasive disease: 24 (47%) were diagnosed with meningoencephalitis, 20 (39.2%) with encephalitis, one (2%) with meningitis, and seven (13.7%) with acute flaccid paralysis. Twenty patients (39.2%) had movement disorders (tremor, myoclonus, bradykinesia, or rigidity). The case fatality rate was 17.6%. In multivariate analysis, older age (OR: 1.09, CI: 1.03-1.19, p = 0.042) and secondary bacterial infection during hospitalization (OR: 10, CI: 1.55-64.95, p = 0.015) were associated with fatality.

conclusionWe highlighted the increasing number of cases and diagnostic challenges by describing the highest number of the patients with WNV infections in Türkiye. Raising awareness among healthcare professionals, facilitating access to diagnostic tests, and developing rapid, reliable, and easily applicable tests would enable early diagnosis and help improve outcomes.

Indexed as

Communicable Diseases, EmergingWest Nile FeverWest Nile virusAdultAgedAged, 80 and overDisease OutbreaksFemaleHumansMaleMiddle AgedRetrospective StudiesTertiary Care CentersTurkeyAcute flaccid paralysisEncephalitisMeningoencephalitisVector-borne diseaseWest nile virus infections

Identifiers

PMID40293623
PMCPMC12241203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.